Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
791
datasets available to search
ShareScore release 0.9.0
Dataset results
791 results for “contraceptives”
A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants
ClinicalTrials.gov study NCT04131517. IPD Sharing: NO. Countries: 1. Publications: 1.
MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning
ClinicalTrials.gov study NCT02100124. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Obesity, Oral Contraception, and Ovarian Suppression
ClinicalTrials.gov study NCT00827632. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study
ClinicalTrials.gov study NCT02852265. IPD Sharing: NO. Countries: 1. Publications: 1.
Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females
ClinicalTrials.gov study NCT02792517. IPD Sharing: Not stated. Countries: 1. Publications: 1.
International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC)
ClinicalTrials.gov study NCT00335257. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Innovative Model of Patient-Centered ConTraception
ClinicalTrials.gov study NCT02364037. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
ClinicalTrials.gov study NCT01388491. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).
ClinicalTrials.gov study NCT00185458. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
ClinicalTrials.gov study NCT00551616. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Participation in self-help groups among women seeking contraceptives in Nairobi
Open the record for dataset details and reuse information.
Feasibility of a contraceptive-specific electronic health record system to promote the adoption of pharmacist-prescribed contraceptive services in community pharmacies in the United States
Open the record for dataset details and reuse information.
Data from: Consistent condom use among highly effective contraceptive users in an HIV-endemic area in rural Kenya
<p><strong>Background</strong>: Women of reproductive age are at the highest risk of both HIV infection and unintended pregnancy in sub-Saharan Africa. Highly effective contraceptives (HECs) such as hormonal injectable and implants are widely used in this region. HECs are effective for preventing pregnancies. However, unlike condoms, HECs offer no protection against HIV. Dual-method use, or the use of condoms with HECs, is an ideal option to reduce HIV risk but is infrequently practiced. Rather, women tend not to use condoms when they use HECs and increase their HIV risk from their sexual partners. However, it remains unknown whether HIV status affects such tendency. Given the increasing popularity of HECs in sub-Saharan Africa, this study examined the association between the use of HECs and condom use among HIV-positive and negative women. Methods: A cross-sectional study was conducted among 833 sexually active women aged 18-49 years, recruited from six clinics in Siaya county, Kenya. From March to May 2017, female research assistants interviewed the women using a structured questionnaire. Multiple logistic regression analysis was conducted to examine the association between HEC use and consistent condom use in the past 90 days, adjusting for potential confounders. It was also examined with regular partners (husbands or live-in partners) and non-regular partners, separately. In addition, a sub-sample analysis of HIV-negative or unknown women was conducted. Results: In total, 735 women were available for the analysis. Among the women, 231 (31.4%) were HIV-positive. HIV-positive women were more likely to use HECs than HIV-negative or status unknown women (70.1% vs. 61.7%, p=0.027). HEC use was significantly associated with decreased condom use with a regular partner (adjusted odds ratio (AOR)=0.25; 95% CI 0.15-0.43, p<0.001) and a non-regular partner (AOR=0.25; 95% CI 0.11-0.58, p=0.001). However, compared with HIV-negative or status unknown women, HIV-positive women were more likely to use HECs and condoms consistently with a regular partner (AOR=6.54, 95% CI 2.15-20.00, p=0.001). Other factors significantly associated with consistent condom use included partner's positive attitude toward contraception, partner's HIV-positive status, high HIV risk perception, and desire for children in the future. Conclusion: Dual-method use was limited among HIV-negative women and women who had HIV-negative partners due to inconsistent condom use. The use of HECs was significantly associated with decreased condom use, regardless of partner type and their HIV status. Due to this inverse association, HIV-negative women may increase their HIV risk from their sexual partners. Therefore, interventions should be strengthened to reduce their dual risks of HIV infection and unintended pregnancy by promoting dual-method use. Family planning services should strengthen counseling on the possible risk of HIV infection from their sexual partners and target not only women but also their partners, who may play a key role in condom use.</p>
A promising target for non-hormonal contraception – The a/b Hydrolase Domain 2
<p>Summary of results in 2022 for a/b Hydrolase Domain 2 (ABHD2) in the scope of the Structural Genomics Consortium's Women’s and Children’s Health Initiative funded by the Bill & Melinda Gates Foundation for characterizing potential targets for new non-hormonal contraceptives.</p>
How COVID-19 continues to affect contraception in Scotland: a retrospective analysis of Scottish prescribing data between 2016 and 2023.
<p>This is the data and script used to analyse data for the publication<em>: How COVID-19 continues to affect contraception in Scotland: a retrospective analysis of Scottish prescribing data between 2016 and 2023.</em></p> <p>Data uploaded here originates from the Scottish Health and Social Care Open Data repository (<a href="https://www.opendata.nhs.scot">https://www.opendata.nhs.scot</a>). For information about field descriptions, please refer to their Data Glossary (<a href="http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/_docs/Glossary-of-Terms.pdf">http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/_docs/Glossary-of-Terms.pdf</a>). These data are used here under the Open Government Licence (<a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/">https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/</a>).</p> <p>I welcome all feedback or questions: <a href="mailto:e.johnson-hall.2023@bristol.ac.uk">e.johnson-hall.2023@bristol.ac.uk</a></p>
The Influence of Oral Contraceptives During Disuse
ClinicalTrials.gov study NCT06275048. IPD Sharing: YES. Countries: 1. Publications: 0.
Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder
ClinicalTrials.gov study NCT05098574. IPD Sharing: NO. Countries: 1. Publications: 1.
Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?
ClinicalTrials.gov study NCT02562053. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)
ClinicalTrials.gov study NCT00511433. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives
ClinicalTrials.gov study NCT01750476. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.